Philips Appoints Jean Botti as Chief Innovation and Strategy Officer

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jean Botti as Chief Innovation and Strategy Officer as part of the company's strategy to capture a larger portion of the HealthTech opportunities. Jean Botti, who will join Philips as of April 1, 2016 from Airbus Group (AIR), will become a member of Philips' Executive Committee and will report directly to Philips CEO Frans van Houten. Jean Botti will succeed Jim Andrew, who left Philips in the fourth quarter of 2015 for personal reasons.

"I am very pleased that Jean Botti has decided to join Philips on our journey to extending our leadership in health technology, capitalizing on opportunities arising from the consumerization and industrialization of healthcare to transform the delivery of care," said Frans van Houten. "Jean has had a remarkable and distinguished career and his achievements at Airbus are impressive, ranging from his ability to continually improve the company’s innovation capabilities and building intelligent systems, to embedding quality across the company’s value chain. His track record in driving innovation and change in high-tech industries will prove extremely valuable for Philips."

Jean Botti (French, 1957) joins Philips from Airbus Group, a global leader in aeronautics, space and related services, where he served as Chief Technical Officer since 2006. Prior to this, he worked in various roles in Europe and the U.S. at among others Renault and General Motors. He graduated from the National Institute of Applied Sciences (INSA) in Toulouse in 1986, with a degree in mechanical engineering. He holds a PhD in mechanical engineering from the Conservatoire des Arts et Métiers in collaboration with the University of Michigan. Jean Botti also earned an MBA from Central Michigan University and a degree in Research and Development Management from the Massachusetts Institute of Technology (MIT).

"I am excited to join a company that has made it its mission to improve the lives of billions of people every year globally and that has such a strong track record in innovation, advanced technologies and design capabilities," said Jean Botti. "I am convinced that my experience in the automotive and aviation industries in terms of digital transformation and process optimization will support Philips' ambitions to drive the personalization and industrialization of care."

The appointment of Jean Botti is the latest example of Philips' efforts to align its organization in order to better capitalize on HealthTech market opportunities.

Recently, and in addition to his role as CEO of Personal Health, Philips appointed Pieter Nota to the newly-created position of Chief Marketing Officer, whose role is to establish an integrated approach to marketing, building out Philips’ capabilities to drive marketing excellence in the rapidly changing world of health technology.

Furthermore, Philips established the Monitoring, Informatics & Connected Care segment, led by Jeroen Tas and comprising Patient Care & Monitoring Solutions, Healthcare Informatics, Emerging Businesses and a newly created Population Health Management business.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...